These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 31183866)

  • 21. BRAF mutations and survival with surgery for colorectal liver metastases: A systematic review and meta-analysis.
    Petrelli F; Arru M; Colombo S; Cavallone M; Cribiu' FM; Villardita V; Floris P; Digiesi L; Severgnini G; Moraes MT; Conti B; Celotti A; Viti M; Sozzi A
    Eur J Surg Oncol; 2024 Jun; 50(6):108306. PubMed ID: 38603866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.
    Margonis GA; Kim Y; Sasaki K; Samaha M; Amini N; Pawlik TM
    Cancer; 2016 Sep; 122(17):2698-707. PubMed ID: 27244540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resection of Colorectal Liver Metastasis: Prognostic Impact of Tumor Burden vs KRAS Mutational Status.
    Tsilimigras DI; Hyer JM; Bagante F; Guglielmi A; Ruzzenente A; Alexandrescu S; Poultsides G; Sasaki K; Aucejo F; Pawlik TM
    J Am Coll Surg; 2021 Apr; 232(4):590-598. PubMed ID: 33383214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection.
    Schirripa M; Bergamo F; Cremolini C; Casagrande M; Lonardi S; Aprile G; Yang D; Marmorino F; Pasquini G; Sensi E; Lupi C; De Maglio G; Borrelli N; Pizzolitto S; Fasola G; Bertorelle R; Rugge M; Fontanini G; Zagonel V; Loupakis F; Falcone A
    Br J Cancer; 2015 Jun; 112(12):1921-8. PubMed ID: 25942399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors influencing recurrence following initial hepatectomy for colorectal liver metastases.
    Hallet J; Sa Cunha A; Adam R; Goéré D; Bachellier P; Azoulay D; Ayav A; Grégoire E; Navarro F; Pessaux P;
    Br J Surg; 2016 Sep; 103(10):1366-76. PubMed ID: 27306949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of KRAS Mutation on Long-Term Outcomes of Patients Undergoing Hepatic Resection for Colorectal Liver Metastases.
    Margonis GA; Spolverato G; Kim Y; Karagkounis G; Choti MA; Pawlik TM
    Ann Surg Oncol; 2015 Dec; 22(13):4158-65. PubMed ID: 26077912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A critical appraisal of the current landscape of resectable BRAF mutated colorectal liver metastases: a systematic review.
    Margonis GA; Wang J; Papakonstantinou D; Beyer K; Kreis ME; D'Angelica M
    Chin Clin Oncol; 2024 Aug; 13(4):51. PubMed ID: 38859602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Critical appraisal of surgical margins according to KRAS status in liver resection for colorectal liver metastases: Should surgical strategy be influenced by tumor biology?
    Rhaiem R; Duramé A; Primavesi F; Dorcaratto D; Syn N; Rodríguez ÁH; Dupré A; Piardi T; Fernández GB; Villaverde AP; Rodríguez Sanjuán JC; Santiago RF; Fernández-Moreno MC; Ferret G; Ben SL; Suárez Muñoz MÁ; Perez-Alonso AJ; Koh YX; Jones R; Martín-Pérez E; Kianmanesh R; Di Martino M
    Surgery; 2024 Jul; 176(1):124-133. PubMed ID: 38519408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association Between Specific Mutations in KRAS Codon 12 and Colorectal Liver Metastasis.
    Margonis GA; Kim Y; Spolverato G; Ejaz A; Gupta R; Cosgrove D; Anders R; Karagkounis G; Choti MA; Pawlik TM
    JAMA Surg; 2015 Aug; 150(8):722-9. PubMed ID: 26038887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRAF mutation is a prognostic biomarker for colorectal liver metastasectomy.
    Teng HW; Huang YC; Lin JK; Chen WS; Lin TC; Jiang JK; Yen CC; Li AF; Wang HW; Chang SC; Lan YT; Lin CC; Wang HS; Yang SH
    J Surg Oncol; 2012 Aug; 106(2):123-9. PubMed ID: 22331825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reevaluating the prognostic role of BRAF mutation in colorectal cancer liver metastases.
    Pikouli A; Papaconstantinou D; Wang J; Kavezou F; Pararas N; Nastos C; Pikoulis E; Margonis GA
    Am J Surg; 2022 May; 223(5):879-883. PubMed ID: 34544580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival Outcomes of Resected BRAF V600E Mutant Colorectal Liver Metastases: A Multicenter Retrospective Cohort Study in Japan.
    Kobayashi S; Takahashi S; Takahashi N; Masuishi T; Shoji H; Shinozaki E; Yamaguchi T; Kojima M; Gotohda N; Nomura S; Yoshino T; Taniguchi H
    Ann Surg Oncol; 2020 Sep; 27(9):3307-3315. PubMed ID: 32661852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes after resection and/or radiofrequency ablation for recurrence after treatment of colorectal liver metastases.
    Hof J; Wertenbroek MW; Peeters PM; Widder J; Sieders E; de Jong KP
    Br J Surg; 2016 Jul; 103(8):1055-62. PubMed ID: 27193207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KRAS status and outcome of liver resection after neoadjuvant chemotherapy including bevacizumab.
    Stremitzer S; Stift J; Gruenberger B; Tamandl D; Aschacher T; Wolf B; Wrba F; Gruenberger T
    Br J Surg; 2012 Nov; 99(11):1575-82. PubMed ID: 23027075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors of BRAF V600E colorectal cancer with liver metastases: a retrospective multicentric study.
    Javed S; Benoist S; Devos P; Truant S; Guimbaud R; Lièvre A; Sefrioui D; Cohen R; Artru P; Dupré A; Bachet JB; de la Fouchardière C; Ploquin A; Turpin A
    World J Surg Oncol; 2022 Apr; 20(1):131. PubMed ID: 35461290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver resection in patients with eight or more colorectal liver metastases.
    Viganò L; Capussotti L; Majno P; Toso C; Ferrero A; De Rosa G; Rubbia-Brandt L; Mentha G
    Br J Surg; 2015 Jan; 102(1):92-101. PubMed ID: 25451181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Double
    Deshwar A; Margonis GA; Andreatos N; Barbon C; Wang J; Buettner S; Wagner D; Sasaki K; Beer A; Løes IM; Pikoulis E; Damaskos C; Garmpis N; Kamphues K; He J; Kaczirek K; Poultsides G; Lønning PE; Mischinger HJ; Aucejo FN; Kreis ME; Wolfgang CL; Weiss MJ
    Anticancer Res; 2018 May; 38(5):2891-2895. PubMed ID: 29715113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Centralized repeated resectability assessment of patients with colorectal liver metastases during first-line treatment: prospective study.
    Isoniemi H; Uutela A; Nordin A; Lantto E; Kellokumpu I; Ovissi A; Kosunen J; Kallio R; Soveri LM; Salminen T; Ålgars A; Lamminmäki A; Halonen P; Ristamäki R; Räsänen J; Karjula H; Vaalavuo Y; Lavonius M; Osterlund P
    Br J Surg; 2021 Jul; 108(7):817-825. PubMed ID: 33749772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of long-term outcome in patients undergoing simultaneous resection of synchronous colorectal liver metastases.
    Lin Q; Ye Q; Zhu D; Wei Y; Ren L; Ye L; Feng Q; Xu P; Zheng P; Lv M; Fan J; Xu J
    PLoS One; 2014; 9(8):e105747. PubMed ID: 25162714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic impact of perihepatic lymph node metastases in patients with resectable colorectal liver metastases.
    Okuno M; Goumard C; Mizuno T; Kopetz S; Omichi K; Tzeng CD; Chun YS; Lee JE; Vauthey JN; Conrad C
    Br J Surg; 2018 Aug; 105(9):1200-1209. PubMed ID: 29664996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.